Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
Integrated Immune, Epithelial and Lipid Pathways in NSAID-Exacerbated Respiratory Disease
Clinical and Translational Allergy
August 2026
Szatkowski P.
Open Access
SERPINB9 is associated with clinical improvement during aspirin therapy in aspirin-exacerbated respiratory disease
Journal of Allergy and Clinical Immunology
2026
Szatkowski P.
Open Access
The Management of NSAID-ERD Patients in the Current Treatment Landscape: Aspirin Desensitization, Biologics, Both, or Neither?
Journal of Allergy and Clinical Immunology in Practice
2026
Stevens W.W.
A Narrative Review of Recent Developments in Aspirin Therapy After Desensitization in NSAIDs-Exacerbated Respiratory Disease
Journal of Inflammation Research
2026
Patel P.K.
Open Access
A Systematic Review of the Specific Role of Biological Therapies in Aspirin-Exacerbated Respiratory Disease
Journal of Investigational Allergology and Clinical Immunology
2026
Lázaro-Sastre M.
Open Access
Efficacy of Aspirin Therapy After Desensitization on Chronic Rhinosinusitis With Nasal Polyps Patients With Asthma and Non-steroidal Anti-inflammatory Drug Exacerbated Respiratory Disease —A Randomized Clinical Trial
Allergy European Journal of Allergy and Clinical Immunology
November 2025
Helevä A.
Open Access
Oral and intranasal aspirin desensitisation for non-steroidal anti-inflammatory drug (NSAID)-exacerbated respiratory disease
Cochrane Database of Systematic Reviews
7 January 2025
Lourijsen E.
All Open Access, Green
Study protocol for a randomized double-blinded placebo-controlled trial on ASA therapy for patients with chronic rhinosinusitis with nasal polyps, NSAID-exacerbated respiratory disease, and asthma
Frontiers in Allergy
2025
Toppila-Salmi S.
Open Access
Aspirin Desensitization for Recalcitrant Chronic Rhinosinusitis with Nasal Polyposis
Advances in Surgical and Medical Interventions for Recalcitrant Chronic Rhinosinusitis
1 January 2025
LaCava A.F.
Aspirin Desensitization in Treatment of Chronic Rhinosinusitis with Nasal Polyposis: Current Protocols and Evidence
Current Treatment Options in Allergy
September 2024
Thiagarajan K.
Open Access
Olfactory Loss in Rhinosinusitis: Mechanisms of Loss and Recovery
International Journal of Molecular Sciences
April 2024
Dekeyser A.
Open Access
Management of Aspirin-Exacerbated Respiratory Disease: What Does the Future Hold?
Otolaryngologic Clinics of North America
April 2024
O'Brien E.K.
Quality of Life in NSAIDs-Exacerbated Respiratory Disease on or off Intranasal Lysine Aspirin Therapy
Applied Sciences Switzerland
February 2024
Pendolino A.L.
Open Access
Nonsteroidal antiinflammatory drug-exacerbated respiratory disease: molecular mechanism, management and treatment
Frontiers in Allergy
2024
Ley-Tomas J.J.
Open Access
Where Are We in the Medical Treatment of CRS with Nasal Polyps/Eosinophilic Chronic Rhinosinusitis
Nasal Polyposis and Its Management Pathogenesis Medical and Surgical Treatment Second Edition
1 January 2024
Lund V.J.
Aspirin-exacerbated respiratory disease: Updates in the era of biologics
Annals of Allergy Asthma and Immunology
September 2023
Mullur J.
Open Access
A Review of Aspirin-exacerbated Respiratory Diseases and Immunological Efficacy of Aspirin Desensitization
Iranian Journal of Allergy Asthma and Immunology
1 October 2022
Esmaeilzadeh H.
Open Access
AERD: Current Roles for Aspirin Desensitization, Surgery, and Biologic Therapies
Current Otorhinolaryngology Reports
June 2022
Damask C.
Aspirin desensitization and biologics in aspirin-exacerbated respiratory disease: Efficacy, tolerability, and patient experience
Annals of Allergy Asthma and Immunology
May 2022
Mullur J.
All Open Access, Green
A retrospective study on long-term efficacy of intranasal lysine-aspirin in controlling NSAID-exacerbated respiratory disease
European Archives of Oto Rhino Laryngology
May 2022
Pendolino A.L.
Open Access
Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: A systematic review and network meta-analysis
Journal of Allergy and Clinical Immunology
April 2022
Oykhman P.
Open Access
Anaphylaxis to Drugs, Biological Agents, and Vaccines
Immunology and Allergy Clinics of North America
February 2022
Shah R.H.
Yardstick for the medical management of chronic rhinosinusitis
Annals of Allergy Asthma and Immunology
February 2022
Borish L.